You are here

MM-121

Merrimack cuts 60% of jobs, narrows R&D focus

Biopharma Dive

Wed, 11/7/18 - 10:36 pm

Merrimack Pharmaceuticals

Merrimack Pharma’s stock plunges (again) on its latest cancer drug trial flop

Endpoints

Fri, 10/19/18 - 09:40 am

Merrimack Pharmaceuticals

non-small cell lung cancer

Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights

Yahoo/Zacks.com

Mon, 06/23/14 - 07:52 pm

Merrimack Pharmaceuticals

Merrimack - Not Bad News?

Seeking Alpha

Thu, 10/31/13 - 08:52 am

Merrimack Pharmaceuticals

Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi

The Fly on the Wall

Thu, 05/23/13 - 09:44 am

Merrimack Pharmaceuticals

Merrimack lung cancer drug fails goal in one mid-stage trial group

Reuters

Thu, 04/4/13 - 09:22 am

Merrimack Pharmaceuticals

non-small cell lung cancer

3 Things to Watch at Merrimack

Motley Fool

Sun, 12/30/12 - 12:12 pm

Merrimack Pharmaceuticals

pancreatic cancer

IPO Preview: Merrimack Pharmaceuticals

Seeking Alpha

Mon, 01/30/12 - 03:51 pm

Merrimack Pharmaceuticals